Independent writing and research on regulatory compliance, market access, sales, and marketing leadership across medical device. From Directors to Boardroom. No sponsored content. No AI-generated filler. Updated when there is something worth saying.
Every search Innotech Recruit runs maps the commercial field layer of that therapy area. The Business Intelligence Report translates that field knowledge into quarterly intelligence: procurement windows, regulatory changes, competitor vulnerabilities, and a specific brief on what to act on before your competitors do.
Average specification influence window in an NHS framework renewal. From the IV Infusion report, May 2026.
Verified intelligence sections per report. Every claim attributed to a named, datable source.
Quarterly delivery. Same therapy area and geography, every time.
Every search Innotech Recruit runs maps the commercial field layer of that therapy area. The talent signals, the field force movements, the open-to-work analysis: none of that comes from a database. It comes from being inside the market. The sourcing discipline is the same as the search business: every claim in the report is attributed to a named, verifiable source, with a date and a confidence rating. Where data couldn’t be confirmed, the gap is stated explicitly. That’s a standard most dedicated intelligence firms don’t meet.
Probably not who to call. You know that. What you don’t have time to monitor is what’s changing around those people right now: a competitor’s earnings call disclosing a product hold, an MHRA safety notice on a rival’s device, an ICB consultation that signals a procurement consolidation 14 months out, a KOL shifting their position in the clinical press. None of those are secrets. All of them are in public sources. The report translates them into what they mean for your commercial position before the window to act closes.
Yes. Reports are prepared for a named recipient and marked confidential. The subscribed report carries your name on the cover. Subscriber preferences are never shared or sold. Intelligence gathered in the course of producing your report is not shared with competitors in your therapy area. Full terms are set out in the BI Subscription Terms.
Request the sample first. Read the Action Intelligence section. If it doesn’t contain something you can act on in the next 90 days, don’t subscribe. The sample is free precisely because the product should sell itself. If you subscribe and the quarterly report doesn’t meet the standard of the sample, contact Blair Anderson directly.
Yes. The bespoke tier is specifically suited to pre-commercialisation market mapping, UK or US. A company awaiting FDA clearance that needs to understand the US commercial landscape before it has a US presence is exactly the right use case. Use the bespoke enquiry form on the BI Report page. Blair Anderson will confirm scope and price within one working day.